Omada Health outlines 22% revenue growth target for 2026 while launching new GLP-1 and cholesterol programs
2026-03-06 01:17:31 ET
More on Omada Health, Inc.
- Omada Health, Inc. (OMDA) Q4 2025 Earnings Call Transcript
- Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Omada Health expects Q4 revenue to be between $72M and $74M
- Seeking Alpha’s Quant Rating on Omada Health, Inc.
- Historical earnings data for Omada Health, Inc.
Read the full article on Seeking Alpha
For further details see:
Omada Health outlines 22% revenue growth target for 2026 while launching new GLP-1 and cholesterol programsNASDAQ: OMDA
OMDA Trading
5.56% G/L:
$14.525 Last:
1,284,323 Volume:
$13.76 Open:



